View clinical trials related to Benign Prostatic Hyperplasia.
Filter by:The aim of this study was to investigate the metabolites of one-carbon metabolism [choline, betaine, dimethylglycine, folate, S-adenosylhomocysteine, S-adenosylmethionine, homocysteine, cystathionine), and methylmalonic acid (MMA) (marker of vitamin B12 status)] and phospholipid classes in men with primary prostate cancer and controls with benign hyperplasia. Moreover, choline metabolites were studied in relation to tumor grad and age.
The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.
The Changes of Urine Growth Factors Level in Patients With Benigh Prostate Hyperplasia after medical treatment.
The investigators wish to perform a prospective study at the Men's Health Clinic in Winnipeg, Manitoba to accomplish two goals: 1) Prospectively describe 1 year outcomes for MIST therapies performed at the clinic 2) perform a head to head comparison of Rezum water vapor therapy vs the iTind device in respect to symptom score improvement, uroflow parameters and side effect profile.
A randomized, double-blind, placebo-controlled, parallel group study to compare 2 extracts of saw palmetto versus placebo on the symptoms of benign prostate hyperplasia (BPH) in 120 generally healthy participants, 45 - 80 years.
To evaluate the effect of transurethral resection of the prostate while preserving Urethral Mucosa at the Prostatic Apex on retrograde ejaculation and postoperative urine continence in patients with BPH after surgery
There are many factors that affect uroflowmetry parameters. One of these is the urination position. Research has mostly focused on standing and sitting urination positions. However, those who prefer the standing position as a habit can urinate by opening the zipper or lowering the trousers. Although the effect of these two applications on uroflowmetry parameters in healthy men has been investigated in only one study, their effect on patients with lower urinary tract symptoms has not been examined.
This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.
The aim of the current study is to evaluate the efficacy of transperineal focal microwave ablation (TMA) of the prostate transition zone as a new treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) within a prospective single-institutional pilot study.
Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery.